Biofilm of Helicobacter pylori: Life Cycle, Features, and Treatment Options
- PMID: 37627679
- PMCID: PMC10451559
- DOI: 10.3390/antibiotics12081260
Biofilm of Helicobacter pylori: Life Cycle, Features, and Treatment Options
Abstract
Helicobacter pylori is a gastric pathogen that infects nearly half of the global population and is recognized as a group 1 carcinogen by the Word Health Organization. The global rise in antibiotic resistance has increased clinical challenges in treating H. pylori infections. Biofilm growth has been proposed to contribute to H. pylori's chronic colonization of the host stomach, treatment failures, and the eventual development of gastric diseases. Several components of H. pylori have been identified to promote biofilm growth, and several of these may also facilitate antibiotic tolerance, including the extracellular matrix, outer membrane proteins, shifted morphology, modulated metabolism, efflux pumps, and virulence factors. Recent developments in therapeutic approaches targeting H. pylori biofilm have shown that synthetic compounds, such as small molecule drugs and plant-derived compounds, are effective at eradicating H. pylori biofilms. These combined topics highlight the necessity for biofilm-based research in H. pylori, to improve current H. pylori-targeted therapeutic approaches and alleviate relative public health burden. In this review we discuss recent discoveries that have decoded the life cycle of H. pylori biofilms and current biofilm-targeted treatment strategies.
Keywords: Helicobacter pylori; abiotic/biotic adhesion; anti-biofilm strategies; antibiotic resistance; biofilms; clinical treatment strategies; dispersion; extra polymeric substance; planktonic.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Helicobacter pylori Efflux Pumps: A Double-Edged Sword in Antibiotic Resistance and Biofilm Formation.Int J Mol Sci. 2024 Nov 14;25(22):12222. doi: 10.3390/ijms252212222. Int J Mol Sci. 2024. PMID: 39596287 Free PMC article. Review.
-
The Role of Helicobacter pylori Heat Shock Proteins in Gastric Diseases' Pathogenesis.Int J Mol Sci. 2025 May 24;26(11):5065. doi: 10.3390/ijms26115065. Int J Mol Sci. 2025. PMID: 40507876 Free PMC article. Review.
-
Transcending antibiotic resistance: The potential of mass Galla chinensis et camelliae Fermentata to Dismantle Helicobacter pylori biofilms and enhance anti-biotic activity.J Ethnopharmacol. 2024 Nov 15;334:118594. doi: 10.1016/j.jep.2024.118594. Epub 2024 Jul 18. J Ethnopharmacol. 2024. PMID: 39032662
-
Helicobacter pylori Biofilm and New Strategies to Combat it.Curr Mol Med. 2021;21(7):549-561. doi: 10.2174/1566524020666201203165649. Curr Mol Med. 2021. PMID: 33272177 Review.
-
Helicobacter pylori Biofilm-Related Drug Resistance and New Developments in Its Anti-Biofilm Agents.Infect Drug Resist. 2022 Apr 5;15:1561-1571. doi: 10.2147/IDR.S357473. eCollection 2022. Infect Drug Resist. 2022. PMID: 35411160 Free PMC article. Review.
Cited by
-
Helicobacter pylori Efflux Pumps: A Double-Edged Sword in Antibiotic Resistance and Biofilm Formation.Int J Mol Sci. 2024 Nov 14;25(22):12222. doi: 10.3390/ijms252212222. Int J Mol Sci. 2024. PMID: 39596287 Free PMC article. Review.
-
Helicobacter pylori Outer Membrane Proteins and Virulence Factors: Potential Targets for Novel Therapies and Vaccines.Pathogens. 2024 May 8;13(5):392. doi: 10.3390/pathogens13050392. Pathogens. 2024. PMID: 38787244 Free PMC article. Review.
-
Towards Effective Helicobacter pylori Eradication: Emerging Therapies in the Wake of Antibiotic Resistance.Int J Mol Sci. 2025 Jun 24;26(13):6064. doi: 10.3390/ijms26136064. Int J Mol Sci. 2025. PMID: 40649842 Free PMC article. Review.
-
Enhanced fatty acid biosynthesis by Sigma28 in stringent responses contributes to multidrug resistance and biofilm formation in Helicobacter pylori.Antimicrob Agents Chemother. 2024 Sep 4;68(9):e0085024. doi: 10.1128/aac.00850-24. Epub 2024 Jul 24. Antimicrob Agents Chemother. 2024. PMID: 39046242 Free PMC article.
-
Optimization of Helicobacter pylori Biofilm Formation in In Vitro Conditions Mimicking Stomach.Int J Mol Sci. 2024 Sep 11;25(18):9839. doi: 10.3390/ijms25189839. Int J Mol Sci. 2024. PMID: 39337326 Free PMC article.
References
-
- Dubois A., Fiala N., Heman-Ackah L.M., Drazek E., Tarnawski A., Fishbein W.N., Perez-Perez G.I., Blaser M.J. Natural gastric infection with Helicobacter pylori in monkeys: A model for spiral bacteria infection in humans. Gastroenterology. 1994;106:1405–1417. doi: 10.1016/0016-5085(94)90392-1. - DOI - PubMed
-
- Hooi J.K.Y., Lai W.Y., Ng W.K., Suen M.M.Y., Underwood F.E., Tanyingoh D., Malfertheiner P., Graham D.Y., Wong V.W.S., Wu J.C.Y., et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017;153:420–429. doi: 10.1053/j.gastro.2017.04.022. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources